Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00060905 · ClinicalTrials.gov registry record · Phase 3
An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder
A Phase 3 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 3
- Development phase
- 370
- Enrollment target
NCT00060905 is a Phase 3 study that has completed, run by Abbott. The registered enrollment target is 370 participants.
The verdict
NCT00060905, a Phase 3 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 370 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and effectiveness of Depakote ER compared to placebo in the treatment of bipolar disorder, manic or mixed type in adults.
Interventions
- DRUG Divalproex Sodium (Depakote ER)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 370 participants |
| Start Date | 2003-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00060905
The ClinicalTrials.gov registry entry for NCT00060905 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 370 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Divalproex Sodium (Depakote ER) is the first listed.
NCT00060905 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00060905 about?
NCT00060905 is a clinical study titled "An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder". The purpose of this study is to determine the safety and effectiveness of Depakote ER compared to placebo in the treatment of bipolar disorder, manic or mixed type in adults.
What is the current status of trial NCT00060905?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 370 participants. The study started on 2003-01.
What interventions are being tested in trial NCT00060905?
The interventions under investigation include: Divalproex Sodium (Depakote ER) (DRUG).
Who is sponsoring clinical trial NCT00060905?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.